GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
77
c/compounding·posted 6 months ago by u/elise_ramos

Sweden: state board, and what it actually costs here

Regulatory

Sweden: state board, and what it actually costs here, and I am aware this is a minority view on this board.

Concentration on the compounded vial was different from what I had been using and I nearly did the arithmetic on autopilot.

Asked for the beyond-use date basis and got a real answer with a stability reference attached. Not universal, apparently.

Switched between two compounded preparations and the concentration on the label was different. Redid the arithmetic on paper before drawing anything.

Sceptical readings welcome. The confident ones are the ones I distrust.

81 up / 4 down95% upvoted15 commentsid nwushm16 Jan 2026

15 comments

15 in this archive, depth 6

best — the order this archive was captured in

u/quiet_moderatorMOD11 points·6 months ago

Reminder that nothing here is medical advice and this board cannot tell you which arrangement to choose.

replysharereportpermalink
u/yannick_petrov9 points·6 months ago

What concentration is on the label, and does it match what you were expecting?

replysharereportpermalink
u/julia_erdogan6 points·6 months ago

The shortage list is the legal hinge: the permissions that allow certain compounding to happen at scale are tied to a drug’s shortage status, which changes.

replysharereportpermalink
u/rekha_mwangi5 points·6 months ago

Yes — asking which facility, by name, is the single most useful question and most clinics will answer it.

replysharereportpermalink
[deleted]2 points·6 months ago

[deleted]

replysharereportpermalink
u/elise_ramos2 points·6 months ago

the shortage list is the whole legal hinge and people skip it

replysharereportpermalink
u/formulary_fighterappeals2 points·6 months ago

the shortage list is the whole legal hinge and people skip it

This is the distinction the whole board runs on. Everything else follows from it.

replysharereportpermalink
u/solene_eriksen1 point·6 months ago

Yes. The shortage list is the legal hinge for the whole arrangement and its status is public.

replysharereportpermalink
u/hugo_bergstrom1 point·6 months ago·edited

the API source is the question nobody asks and everybody should

replysharereportpermalink
u/sigrid_kaufmann1 point·6 months ago

Correction: patient-specific refers to the prescription, not to a bespoke formulation. Common misreading and it changes the argument.

replysharereportpermalink
u/amara_kuipers1 point·6 months ago·edited

a 503B has to register and report, so there is a paper trail to ask for

replysharereportpermalink
u/camila_sandvik4 points·6 months ago

Careful. Naming a clinic without describing what actually happened turns this into a different kind of thread.

replysharereportpermalink
u/lipid_panel_larrybloodwork3 points·6 months ago·edited

Push back: "compounded is fine because a pharmacy made it" skips every question this board exists to ask.

replysharereportpermalink
u/rina_sobczak4 points·6 months ago

shortage status changes and the whole arrangement changes with it

replysharereportpermalink
u/tobias_vukovic1 point·6 months ago

Same view. If the intake asked you nothing, the intake was a formality and you should factor that in.

replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/compounding

Compounded GLP-1s as a supply route: the 503A/503B distinction, the shortage-list mechanics that made compounding legal and then didn't, state board rules, telehealth prescriber models, and what a compounding pharmacy will and will not tell you about its API source.

53kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/compounding rules
  1. Regulatory claims need a citation to the actual rule, notice or docket.
  2. No pharmacy referral codes. Naming a pharmacy is fine; recruiting for it is not.
  3. API source questions are on-topic and pharmacies dodging them is newsworthy.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.